Harvey Cash Net Worth & Insider Trades
Harvey Cash Transcept Pharmaceuticals Inc
What is Harvey Cash's Net Worth?
The current estimated net worth of Transcept Pharmaceuticals Inc's Harvey Cash is estimated to be about $67.98M . Harvey Cash owns about 1,983,884 units of Transcept Pharmaceuticals Inc common stock. Recently at Transcept Pharmaceuticals Inc, Harvey Cash has sold an estimated value of $0 worth.
What is Harvey Cash's Past Insider Trading?
Harvey Cash's largest purchase order was 217,228 units , worth over $1.57M on September 23, 2011. In total, Harvey Cash has made about 1 transaction recently at Transcept Pharmaceuticals Inc. Harvey Cash usually trades in September, with the busiest year in 2011.
InterWest Partners IX LP, ARNOLD ORONSKY, PHILIP GIANOS, Gilbert Kliman, HARVEY CASH, Thomas Rosch, Stephen Holmes, KHALED NASR, BRUCE CLEVELAND, Douglas Pepper
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Harvey Cash's' Mailing Address?
- Mailing address is 13455 Noel Road Suite 1670 Dallas TX 75240 TX
What are Transcept Pharmaceuticals Inc's Past Insider Trades?
Transcept Pharmaceuticals Inc's most recent insider trade came on December 17, 2013 by Roumell Asset Management Llc who sold 1,470 units worth $5.2K . In the last 4 years, insiders at Transcept Pharmaceuticals Inc have sold an estimated value of $6.52M and bought an estimated value of $9.99M worth of shares. Insider trading is most common in February, with the busiest year in 2011. The most active traders at the company are Roumell Asset Management Llc, Glenn Oclassen, President and CEO, and Marilyn Wortzman, VP .
Transcept Pharmaceuticals Inc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||